Ozempic Dosing: How Often Do You Take It?

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections, including the brand-name medication Ozempic, are given once per week as a subcutaneous injection. Most patients start at a lower dose and gradually increase their dose every four weeks under medical supervision. PlexusDx provides compounded semaglutide injections from licensed 503A pharmacies, allowing patients to follow a personalized dosing protocol without insurance requirements.

Weekly Semaglutide Injection Schedule

Semaglutide injections follow a simple once-weekly dosing pattern, meaning you inject yourself one time every seven days. This convenient schedule makes adherence easier compared to daily oral medications. Patients typically choose the same day each week—such as Monday morning or Sunday evening—to maintain consistency and develop a routine.

The standard starting dose for semaglutide is 0.25 mg once weekly. This low initial dose allows your body to adapt to the medication while minimizing gastrointestinal side effects. Your healthcare provider monitors your response over the first month before recommending any dose increase.

Dose Titration: How Your Semaglutide Dose Increases

Most semaglutide treatment plans follow a four-week titration schedule, where the dose increases every 28 days if tolerated. The typical progression moves from 0.25 mg to 0.5 mg, then 1.0 mg, and finally 1.7 mg or 2.4 mg depending on your goals and response. Each dose level is maintained for four weeks to allow your body to adapt and to assess appetite suppression and weight loss results.

Not every patient needs to reach the maximum dose. Some individuals achieve their target weight loss and appetite control at intermediate doses like 1.0 mg or 1.7 mg weekly. Your PlexusDx-affiliated clinician will evaluate your progress at each stage and adjust based on your individual response, tolerability, and weight loss goals.

PlexusDx compounds semaglutide at multiple strength levels to support whatever dose your body requires. Your dose may need to go up. Your price won't—PlexusDx maintains flat monthly pricing regardless of which strength you're using.

Consistency Matters: Timing Your Weekly Injections

Taking your semaglutide injection on the same day each week helps maintain steady medication levels in your bloodstream. Research shows that consistent weekly administration produces the most predictable appetite suppression and metabolic effects. Delaying or advancing your injection by a day or two won't cause harm, but sticking to your chosen weekly day optimizes results.

You can inject semaglutide at any time of day—morning, afternoon, or evening—based on your personal preference. The key is consistency rather than timing relative to meals. Many patients find that injecting on the same day of the week becomes automatic, like a weekly appointment with yourself.

When Dosing Adjustments May Be Needed

Your semaglutide dose may need adjustment if you experience inadequate weight loss after 12 weeks at a given dose level, or if you develop side effects that make your current dose uncomfortable. Nausea, vomiting, or constipation at higher doses sometimes improves by pausing dose increases or staying at your current level longer. Your clinician may also recommend dose adjustments if your weight loss plateaus or if you reach your target weight earlier than expected.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx serves all 50 states with no insurance required and provides compounded semaglutide from licensed 503A pharmacies. Whether you're starting at 0.25 mg or maintaining 2.4 mg weekly, your monthly cost remains predictable and transparent—starting at just $149 per month.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How often do you take semaglutide injections?

Semaglutide is administered as a once-weekly subcutaneous injection, typically on the same day each week. Most patients start with 0.25 mg and increase by 0.25 mg every four weeks as tolerated, with most people reaching effective doses between 1.0 mg and 2.4 mg weekly.

Can you skip a dose of semaglutide or take it early?

Skipping a dose or taking it a few days early occasionally won't cause serious problems, but consistency is important for steady medication levels and best results. If you miss a dose, resume your regular schedule the following week rather than doubling up.

What happens if I don't increase my semaglutide dose on schedule?

You can stay at any dose level as long as you're achieving meaningful weight loss and tolerating it well. Some patients find that 1.0 mg or 1.7 mg weekly provides optimal results without needing to reach the maximum 2.4 mg dose. Your clinician will individualize your titration based on your response.

Does semaglutide dosing from PlexusDx work differently than brand-name Ozempic?

PlexusDx compounded semaglutide from licensed 503A pharmacies contains the same active ingredient and follows the same weekly injection schedule as Ozempic. The main difference is accessibility and cost—PlexusDx requires no insurance, serves all 50 states, and maintains flat monthly pricing at $189/mo month-to-month, or from $149/mo on the 6-month plan, regardless of your dose strength.

How can genetic testing help with my semaglutide dosing?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic What Is It
• Ozempic Dosing
• What Is Genetic Peptide Testing And Why It Matters Before You Start A Protocol
• What Causes Flatulence And How Can You Control It Effectively

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.